Compounds and methods for the treatment of EGFR positive diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9314536
APP PUB NO 20140178412A1
SERIAL NO

13835537

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are anti-EGFR antibodies conjugated with maytansinoid drugs for targeted delivery to disease tissues. Methods related to the preparation and uses of such antibody drug conjugates to treat EGFR positive cells in cancers are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIO-THERA SOLUTIONS LTD CO11 KAIYUAN BLVD BLDG A6-5F GUANGZHOU SCIENCE CITY 510530

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Shengfeng Belmont, US 46 222
Qin, Chao Guangzhou, CN 69 355

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 19, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00